Risultati della ricerca - Simone Rubant

  • Mostra 1 - 5 risultati su 5
Raffina i risultati
Lista   Griglia  
  1. 1

    Disease severity, treatment patterns, and quality of life in patients with moderate-to-severe psoriasis routinely managed with systemic treatment: results of the CRYSTAL observatio... di Liisi Raam, Ilona Hartmane, Skaidra Valiukevičienė, Arfenya E. Karamova, Eniko Telegdy, Ivan Botev, Diana Marina, Simone Rubant, Teotonio Albuquerque, Maria Magdalena Constantin

    Pubblicazione 2024-05-01
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2

    Correction: Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational... di Diamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, Andrea Szegedi, Paula C. Luna, Charles W. Lynde, Ahmed M. Soliman, Hongwei Wang, Christian Kaufmann, Doug G. Ashley, Tshepiso Madihlaba, Simone Rubant, Kim A. Papp

    Pubblicazione 2025-05-01
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3

    Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 ... di Diamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, Andrea Szegedi, Paula C. Luna, Charles W. Lynde, Ahmed M. Soliman, Hongwei Wang, Christian Kaufmann, Doug G. Ashley, Tshepiso Madihlaba, Simone Rubant, Kim A. Papp

    Pubblicazione 2025-02-01
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4

    Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Stud... di Richard B. Warren, Lev Pavlovsky, Antonio Costanzo, Michael Bukhalo, Neil J. Korman, Yu-Huei Huang, Georgios Kokolakis, Andreas Pinter, Nadia Ibrahim, Yanbing Zheng, Leonidas Drogaris, Vassilis Stakias, Ahmed M. Soliman, Simone Rubant, Diamant Thaçi

    Pubblicazione 2024-11-01
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5

    Correction: Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm... di Richard B. Warren, Lev Pavlovsky, Antonio Costanzo, Michael Bukhalo, Neil J. Korman, Yu-Huei Huang, Georgios Kokolakis, Andreas Pinter, Nadia Ibrahim, Yanbing Zheng, Leonidas Drogaris, Vassilis Stakias, Ahmed M. Soliman, Simone Rubant, Diamant Thaçi

    Pubblicazione 2025-01-01
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: